Ginkgo Bioworks
DNA
DNA
342 hedge funds and large institutions have $2.22B invested in Ginkgo Bioworks in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 109 increasing their positions, 99 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 46
2% less funds holding
Funds holding: 348 → 342 (-6)
20% less call options, than puts
Call options by funds: $6.11M | Put options by funds: $7.6M
Holders
342
Holding in Top 10
3
Calls
$6.11M
Puts
$7.6M
Top Buyers
| 1 | +$81.4M | |
| 2 | +$27.7M | |
| 3 | +$6.08M | |
| 4 |
VAS
Vestmark Advisory Solutions
Wakefield,
Massachusetts
|
+$5.04M |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$4.04M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$4.25M | |
| 3 | -$4.1M | |
| 4 |
BHCM
Boulder Hill Capital Management
New York
|
-$2.65M |
| 5 |
HF
HRT Financial
New York
|
-$2.46M |